Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.0B | 3.3B | 3.2B | 2.8B |
Cost of revenue | 2.7B | 2.9B | 2.8B | 2.5B |
Gross profit | 310M | 400M | 375M | 358M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 261M | 277M | 265M | 270M |
Other operating expenses | — | — | — | — |
Operating income | 49M | 123M | 110M | 88M |
Non operating interest income | ||||
Income | 11M | — | 12M | 11M |
Expense | 43M | 0 | 45M | 34M |
Other income expense | -110M | 8M | -35M | -12M |
Pretax income | -93M | 97M | 42M | 53M |
Tax provision | 2M | -3M | 7M | 14M |
Net income | -95M | 100M | 35M | 39M |
Basic EPS | -0.8 | — | 0.3 | 0.3 |
Diluted EPS | -0.8 | — | 0.3 | 0.3 |
Basic average shares | 133.3M | — | 133.8M | 133.8M |
Diluted average shares | 133.3M | — | 134.2M | 134.1M |
EBITDA | 174M | 217M | 238M | 203M |
Net income from continuing op. | -95M | 100M | 35M | 39M |
Minority interests | -1M | 0 | -2M | -1M |
Preferred stock dividends | — | — | — | — |